Pharmaceutical Industry Prepares for Regulatory Shift as FTC Shifts Antitrust Tactics
Despite the FTC's aggressive stance and robust antitrust agenda, companies continue to pursue significant mergers, challenging current antitrust policies. Criticisms of the FTC's effectiveness and calls for legislative reform underscore…